{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T22:32:47Z","timestamp":1698705167980},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,7,14]],"date-time":"2006-07-14T00:00:00Z","timestamp":1152835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s00228-006-0165-4","type":"journal-article","created":{"date-parts":[[2006,7,13]],"date-time":"2006-07-13T12:58:24Z","timestamp":1152795504000},"page":"627-631","source":"Crossref","is-referenced-by-count":8,"title":["Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid\/theophylline ratios"],"prefix":"10.1007","volume":"62","author":[{"given":"Yeomin","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Doo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Un","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Q.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Seok","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junghan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,14]]},"reference":[{"key":"165_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1742-1241.1986.tb07966.x","volume":"40","author":"WV Evans","year":"1986","unstructured":"Evans WV (1986) Slow release theophylline in chronic bronchitis-a comparative study. Br J Clin Pract 40:245\u2013250","journal-title":"Br J Clin Pract"},{"key":"165_CR2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archinte.159.9.989","volume":"159","author":"M Shannon","year":"1999","unstructured":"Shannon M (1999) Life-threatening events after theophylline overdose: a 10-year prospective analysis. Arch Intern Med 159:894\u2013989","journal-title":"Arch Intern Med"},{"key":"165_CR3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003088-197803040-00002","volume":"3","author":"RI Ogilvie","year":"1977","unstructured":"Ogilvie RI (1977) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3:267\u2013293","journal-title":"Clin Pharmacokinet"},{"key":"165_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008571-199204000-00004","volume":"2","author":"L Gu","year":"1992","unstructured":"Gu L, Gonzalez FJ, Kalow W, Tang BK (1992) Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2:73\u201377","journal-title":"Pharmacogenetics"},{"key":"165_CR5","first-page":"208","volume":"122","author":"TS Jennings","year":"1993","unstructured":"Jennings TS, Nafziger AN, Davidson L, Bertino JS Jr (1993) Gender differences in hepatic induction and inhibition of theophylline pharmacokinetics and metabolism. J Lab Clin Med 122:208\u2013216","journal-title":"J Lab Clin Med"},{"key":"165_CR6","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1373\/clinchem.2004.035337","volume":"50","author":"J Song","year":"2004","unstructured":"Song J, Park KU, Park HD, Yoon Y, Kim JQ (2004) High-throughput liquid chromatography-tandem mass spectrometry assay for plasma theophylline and its metabolites. Clin Chem 50:2176\u20132179","journal-title":"Clin Chem"},{"key":"165_CR7","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1021\/bi00425a019","volume":"27","author":"M Umeno","year":"1988","unstructured":"Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ (1988) Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry 27:9006\u20139013","journal-title":"Biochemistry"},{"key":"165_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.jbchem.a123619","volume":"110","author":"S Hayashi","year":"1991","unstructured":"Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5\u2032-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem (Tokyo) 110:559\u2013565","journal-title":"J Biochem (Tokyo)"},{"key":"165_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/0049825031000086400","volume":"33","author":"N Hanioka","year":"2003","unstructured":"Hanioka N, Tanaka-Kagawa T, Miyata Y, Matsushima E, Makino Y, Ohno A, Yoda R, Jinno H, Ando M (2003) Functional characterization of three human cytochrome P450 2E1 variants with amino acid substitutions. Xenobiotica 33:575\u2013586","journal-title":"Xenobiotica"},{"key":"165_CR10","first-page":"248","volume":"27","author":"IM Danko","year":"2005","unstructured":"Danko IM, Chaschin NA (2005) Association of CYP2E1 gene polymorphism with predisposition to cancer development. Exp Oncol 27:248\u2013256","journal-title":"Exp Oncol"},{"key":"165_CR11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0009-9236(03)00013-4","volume":"73","author":"Y Obase","year":"2003","unstructured":"Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H, Kinoshita M, Kohno S (2003) Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 73:468\u2013474","journal-title":"Clin Pharmacol Ther"},{"key":"165_CR12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1289\/ehp.021101213","volume":"110","author":"J Wan","year":"2002","unstructured":"Wan J, Shi J, Hui L, Wu D, Jin X, Zhao N, Huang W, Xia Z, Hu G (2002) Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ Health Perspect 110:1213\u20131218","journal-title":"Environ Health Perspect"},{"key":"165_CR13","first-page":"113","volume":"42","author":"EA Thompson","year":"1988","unstructured":"Thompson EA, Deeb S, Walker D, Motulsky AG (1988) The detection of linkage disequilibrium between closely linked markers: RFLP at the AI-CIII apolipoprotein genes. Am J Hum Genet 42:113\u2013124","journal-title":"Am J Hum Genet"},{"key":"165_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/oxfordjournals.jbchem.a124526","volume":"116","author":"J Watanabe","year":"1994","unstructured":"Watanabe J, Hayashi S, Kawajiri K (1994) Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5\u2032-flanking region. J Biochem (Tokyo) 116:321\u2013326","journal-title":"J Biochem (Tokyo)"},{"key":"165_CR15","first-page":"495","volume":"8","author":"L Marchand Le","year":"1999","unstructured":"Le Marchand L, Wilkinson GR, Wilkens LR (1999) Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev 8:495\u2013500","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"165_CR16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/00365520310004489","volume":"38","author":"S Kato","year":"2003","unstructured":"Kato S, Tajiri T, Matsukura N, Matsuda N, Taniai N, Mamada H, Yoshida H, Kiyam T, Naito Z (2003) Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive Japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism. Scand J Gastroenterol 38:886\u2013893","journal-title":"Scand J Gastroenterol"},{"key":"165_CR17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/jhep.2003.50144","volume":"37","author":"YS Huang","year":"2003","unstructured":"Huang YS, Chern HD, Su WJ, Wu JC, Chang SC, Chiang CH, Chang FY, Lee SD (2003) Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 37:924\u2013930","journal-title":"Hepatology"},{"key":"165_CR18","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1248\/bpb.18.1590","volume":"18","author":"Y Tanigawara","year":"1995","unstructured":"Tanigawara Y, Komada F, Shimizu T, Iwakawa S, Iwai T, Maekawa H, Hori R, Okumura K (1995) Population pharmacokinetics of theophylline. III. Premarketing study for a once-daily administered preparation. Biol Pharm Bull 18:1590\u20131598","journal-title":"Biol Pharm Bull"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-006-0165-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0165-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T01:43:36Z","timestamp":1683510216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-006-0165-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,14]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1007\/s00228-006-0165-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,14]]}}}